{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:06:52Z","timestamp":1789200412286,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015202","name":"Matthew's Hearts of Hope Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Congenital Heart Disease"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijcchd.2026.100681","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:17:56Z","timestamp":1776727076000},"page":"100681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Changes in pharmacotherapy in adults with Fontan circulation and associations with outcomes"],"prefix":"10.1016","volume":"25","author":[{"given":"Andrew M.","family":"Freddo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Eron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antara","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis Z.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Denduluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Partington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ruckdeschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine D.","family":"Mavroudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Nuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Ortega-Legaspi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Vaikunth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcchd.2026.100681_bib1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00246-010-9807-5","article-title":"The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers","volume":"31","author":"Anderson","year":"2010","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.ijcchd.2026.100681_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023035","article-title":"Use of pulmonary arterial hypertension therapies in patients with a Fontan circulation: current practice across the United Kingdom","volume":"11","author":"Constantine","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ijcchd.2026.100681_bib3","first-page":"S32","article-title":"Redefining expectations of long-term survival after the fontan procedure","volume":"130","author":"d'Udekem","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcchd.2026.100681_bib4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jacc.2015.07.065","article-title":"40-Year Follow-Up after the fontan operation long-term outcomes of 1,052 patients","volume":"66","author":"Pundi","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcchd.2026.100681_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.amjcard.2023.08.176","article-title":"Long-Term outcomes and characteristics associated with mortality of adult patients post fontan surgery: 27-Year single-center experience","volume":"207","author":"Pravda","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcchd.2026.100681_bib6","article-title":"Cardiac medication prescription pattern and Association with transplant-free survival in the adult fontan population","volume":"4","author":"Freddo","year":"2025","journal-title":"JACC (J Am Coll Cardiol): Adv"},{"key":"10.1016\/j.ijcchd.2026.100681_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2017.12.012","article-title":"Outcomes of hospitalization in adults with fontan palliation: the Mayo clinic experience","volume":"198","author":"Egbe","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcchd.2026.100681_bib8","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1002\/ehf2.13294","article-title":"Reaching consensus for unified medical language in fontan care","volume":"8","author":"Alsaied","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ijcchd.2026.100681_bib9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/01.CIR.96.5.1507","article-title":"Enalapril does not enhance exercise capacity in patients after fontan procedure","volume":"96","author":"Kouatli","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcchd.2026.100681_bib10","doi-asserted-by":"crossref","unstructured":"J. Rychik, A.M. Atz, D.S. Celermajer, B.J. Deal, M.A. Gatzoulis, M.H. Gewillig, T.-Y. Hsia, D.T. Hsu, A.H. Kovacs, B.W. McCrindle, J.W. Newburger, N.A. Pike, M. Rodefeld, D.N. Rosenthal, K.R. Schumacher, B.S. Marino, K. Stout, G. Veldtman, A.K. Younoszai, Y. d'Udekem, O. behalf of the A.H.A.C. on C.D. in the Y. and C. on C. and S. Nursing, Evaluation and management of the child and adult with fontan circulation: a scientific statement from the American heart association, Circulation 140 (n.d.) e234\u2013e284. https:\/\/doi.org\/10.1161\/cir.0000000000000696.","DOI":"10.1161\/CIR.0000000000000696"},{"key":"10.1016\/j.ijcchd.2026.100681_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002566","article-title":"Association of digoxin with interstage mortality: results from the pediatric heart network single ventricle reconstruction trial public use dataset","volume":"5","author":"Oster","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ijcchd.2026.100681_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.amjcard.2021.05.048","article-title":"Impact of digoxin use on interstage outcomes of single ventricle heart disease (from a NPC-QIC registry analysis)","volume":"154","author":"Klausner","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcchd.2026.100681_bib13","first-page":"348","article-title":"Temporal trends of digoxin use in patients hospitalized with heart failure analysis from the American heart association get with the guidelines-heart failure registry","volume":"4","author":"Patel","year":"2016","journal-title":"JACC (J Am Coll Cardiol): Heart Fail"},{"key":"10.1016\/j.ijcchd.2026.100681_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2022.02.010","article-title":"ACC\/AHA\/HFSA guideline for the management of heart failure","volume":"28","author":"Heidenreich","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.ijcchd.2026.100681_bib15","first-page":"585","article-title":"Digoxin: the good and the bad, trends cardiovasc","volume":"26","author":"Ziff","year":"2016","journal-title":"M\u00e9d Sur"},{"key":"10.1016\/j.ijcchd.2026.100681_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10557-021-07298-5","article-title":"A multisite retrospective review of direct oral anticoagulants compared to warfarin in adult fontan patients","volume":"37","author":"Kazerouninia","year":"2023","journal-title":"Cardiovasc. Drug Ther"},{"key":"10.1016\/j.ijcchd.2026.100681_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2019.06.014","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study","volume":"299","author":"Yang","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcchd.2026.100681_bib18","article-title":"Increased risk for thromboembolism after fontan surgery: considerations for thromboprophylaxis","volume":"10","author":"Helm","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ijcchd.2026.100681_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijcard.2019.09.077","article-title":"Direct oral anticoagulants in adults with congenital heart disease \u2013 a single centre study","volume":"300","author":"Pujol","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcchd.2026.100681_bib20","article-title":"Recurrent sustained atrial arrhythmias and thromboembolism in fontan patients with total cavopulmonary connection","volume":"33","author":"Egbe","year":"2021","journal-title":"IJC Hear. Vasculum"},{"key":"10.1016\/j.ijcchd.2026.100681_bib21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10741-019-09904-z","article-title":"Heart failure with reduced and preserved ejection fraction in adult congenital heart disease","volume":"25","author":"Vaikunth","year":"2020","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ijcchd.2026.100681_bib22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/CIRCULATIONAHA.119.044352","article-title":"Results of the fontan udenafil exercise longitudinal (FUEL) trial","volume":"141","author":"Goldberg","year":"2019","journal-title":"Circulation"},{"issue":"1560","key":"10.1016\/j.ijcchd.2026.100681_bib23","article-title":"The efficacy and safety of macitentan in Fontan-palliated patients: results of the 52-week randomised, placebo-controlled RUBATO trial","volume":"43","author":"Clift","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcchd.2026.100681_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcchd.2026.100681_bib25","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"}],"container-title":["International Journal of Cardiology Congenital Heart Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668526000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668526000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:48:41Z","timestamp":1789199321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666668526000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S2666668526000303"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcchd.2026.100681","relation":{},"ISSN":["2666-6685"],"issn-type":[{"value":"2666-6685","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in pharmacotherapy in adults with Fontan circulation and associations with outcomes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Congenital Heart Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcchd.2026.100681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100681"}}